To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

财务业绩表现 - 公司第三季度每股亏损0.27美元 显著差于市场预期的每股亏损0.18美元 但较去年同期每股亏损0.29美元有所收窄 [1] - 第三季度营收为14.4亿美元 超出市场预期0.57% 但较去年同期的14.5亿美元略有下降 [2] - 过去四个季度中 公司仅有一次超出每股收益预期 但有三次超出营收预期 [2] 市场表现与估值 - 公司股价年初至今下跌约57.4% 同期标普500指数上涨16.5% 表现远逊于大盘 [3] - 当前市场对下一季度的共识预期为每股亏损0.19美元 营收147亿美元 对本财年的共识预期为每股亏损0.56美元 营收582亿美元 [7] 行业比较与展望 - 公司所属的医疗服务业在Zacks行业排名中处于后43%位置 研究表明排名前50%的行业表现优于后50%行业两倍以上 [8] - 同行业公司Cencora预计在下一季度实现每股收益3.79美元 同比增长13.5% 营收预计为831.6亿美元 同比增长5.2% [9][10] - Cencora的每股收益预期在过去30天内上调了0.3% [9]

agilon health (NYSE:AGL) Q3 2025 Earnings Call November 04, 2025 04:30 PM ET Speaker1Good afternoon, and thank you all for attending the Agilon Health Third Quarter 2025 Earnings Conference call. My name is Brika, and I will be your moderator for today. All lines will be muted during the presentation portion of the call, with an opportunity for questions and answers at the end. I would now like to pass the conference over to your host, Evan Smith, Investor Relations at Agilon Health. Thank you. You may proc ...

3Q Earnings Presentation November 2025 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute. Disclaimers and Forward-Looking Statements FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION Statements in this presentation that are not historical factual statements are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-lo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________ FORM 10-Q _______________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numb ...

Exhibit 99.1 agilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook Continued Progress on Transformation Initiatives Including the Execution of $30 million in 2026 Operating Cost Reductions Westerville, O.H., November 4, 2025 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2025 and provided a full-year 2025 outlook. "In the third quarter w ...

公司治理与法律调查 - 投资权益法律公司Halper Sadeh LLC正对agilon health, inc (NYSE: AGL)的特定高管和董事是否违反其对股东的信义义务展开调查 [1] - 长期持有agilon股票的股东可能寻求公司治理改革、资金返还、法院批准的财务激励奖励或其他救济和利益 [1]

Accessibility StatementSkip Navigation NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Why:Â Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public. So What: If you purchased agilon health securities you may be entitled to compensation without payment of any out of pocket fee ...

公司事件与股价表现 - 公司于2025年8月4日发布第二季度财报 并宣布暂停其先前发布的2025年全年财务指引及相关假设 [3] - 公司执行主席在财报中评论称 行业逆风比此前预期的更为严峻 [3] - 在此消息影响下 公司股价于2025年8月5日暴跌51.5% [3] 潜在法律行动 - Rosen Law Firm宣布对该公司展开调查 涉及可能向投资公众发布重大误导性商业信息的指控 [1] - 该律所正在准备集体诉讼 旨在为投资者挽回损失 [2]

公司事件与股价表现 - agilon health公司于2025年8月4日发布了2025年第二季度业绩报告 并宣布暂停其先前发布的2025年全年财务指引及相关假设 [3] - 公司执行主席在评论业绩时表示 在经历这一过渡年期间 行业逆风比此前预期的更为严峻 [3] - 受此消息影响 agilon health公司股价在2025年8月5日大幅下跌51.5% [3] 潜在法律行动 - 罗森律师事务所宣布 正在调查代表agilon health公司股东提起潜在证券索赔的可能性 指控该公司可能向投资公众发布了具有重大误导性的商业信息 [1] - 律师事务所正在准备集体诉讼 旨在为投资者挽回损失 [2]